Ohayon, MM, O'Hara, R, Vitiello, MV. (2012). Epidemiology of restless legs syndrome: A synthesis of the literature.. Sleep Med Rev. 16....
Allen, RP, Walters, AS, Montplaisir, J, Hening, W, Myers, A, Bell, TJ. (2005). Restless legs syndrome prevalence and impact: REST general...
Hening, W.. (2004). The clinical neurophysiology of the restless legs syndrome and periodic limb movements. Part I: Diagnosis, assessment,...
Buchfuhrer, MJ.. (2012). Strategies for the treatment of restless legs syndrome.. Neurotherapeutics. 9. 776
García-Borreguero, D, Silber, MH, Winkelman, JW, Högl, B, Bainbridge, J, Buchfuhrer, M. (2016). Guidelines for the first-line treatment of...
García-Borreguero, D, Kohnen, R, Silber, MH, Winkelman, JW, Earley, CJ, Högl, B. (2013). The long-term treatment of restless legs syndrome/Willis-Ekbom...
Ferini-Strambi, L, Marelli, S.. (2014). Pharmacotherapy for restless legs syndrome. Expert Opin Pharmacother. 15. 1127
de-Oliveira, CO, Carvalho, LB, Carlos, K, Conti, C, de-Oliveira, MM, Prado, LB. (2016). Opioids for restless legs syndrome.. Cochrane Database...
Trenkwalder, C, Beneš, H, Grote, L, García-Borreguero, D, Högl, B, Hopp, M. (2013). Prolonged release oxycodone-naloxone for treatment of...
Mundipharma receives positive European Commission decision on Targin(r) (oxycodone/naloxone) for the treatment of Restless Legs Syndrome.
de-Biase, S, Merlino, G, Valente, M, Gigli, GL.. (2016). Opioids in the treatment of restless legs syndrome: Pharmacological and clinical...
Los metadatos del artículo han sido obtenidos de
SciELO España
